Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?Apostolia Papalexandri, Αchilles Anagnostopoulos, Riad Saloum et al.|HemaSphere|2018Cited by 22
Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Ioanna Sakellari, Eleni Gavriilaki et al.|International Journal of Molecular Sciences|2023Cited by 6
PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSISChristos Varelas, Ioanna Sakellari, Apostolia Papalexandri et al.|HemaSphere|2023Cited by 1
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Αchilles Anagnostopoulos, Eleni Gavriilaki et al.|Blood|2020Cited by 0
Chronic Graft-Versus-Host Disease Immunoprofiling Reveals T Cell Clonal Dynamics That Correlate with Disease Activity: A Novel Molecular "Biomarker"?Anna Vardi, Anastasia Chatzidimitriou, Elisavet Vlachonikola et al.|Blood|2021Cited by 0